Global demand for copper is set to outpace supply by about 25% by 2040, fueled by data center investment and electrification across economies. Traditional options like opening new mines are expensive, highly speculative, and slow—only around 0.3% of mines in early-stage development ever reach production. The industry is turning to biotech start-ups for solutions to squeeze more copper from existing operations.
Mining Biotech Moves Beyond Microbes
Several ventures have focused on using microbes in heap leaching, where bacteria separate copper from rock or waste materials. But one newcomer is proposing something different. Giraffe Bio is engineering mine-specific chemicals—or biomolecules—derived from microbes to increase copper recovery rates by up to 5%. That’s a large gain compared to the usual 1-2% boost most operators expect.
Rather than introducing live microbes into mining sites—a process that’s often hard to control—Giraffe Bio cultures engineered microorganisms in bioreactors to produce custom compounds. These are then applied in a mine’s existing flotation stage. Flotation is a process in which chemicals help desired minerals float or sink so that they can be separated from waste. Giraffe Bio’s biomolecules are designed to bind closely with copper so that more of it can be recovered, while “depressors” manage unwanted compounds like arsenic by dragging them down in the mix.
Funding and Broader Potential
The startup recently secured $6.4 million in seed funding. Orion Industrial Ventures led the round, with contributions from BHP Ventures, Twynam, Air Capital, and Baruch Future Ventures. Giraffe Bio will deploy this capital toward scaling its lab results into commercial operations.
Although its first target is copper, the company says its platform can be adapted for other metals, such as gold and silver. The engineered biomolecules could also replace toxic chemicals currently used in flotation, potentially reducing environmental impacts while boosting yield.
Legacy methods of increasing copper output—with more drilling, more mines, more ore—face economic, geographic, regulatory, and environmental constraints. Biotechnology offers a way to optimize what miners already have.
Analytical Takeaway:
Using bespoke biomolecules for copper extraction is promising, but scaling will be tough. Mines operate under extreme and variable conditions—temperature, pH, mineral mixes—so compounds that work in one location may fail in another. Also, commercializing biotechnology in an industry built on well-understood chemicals demands trust, regulatory approval, and consistent performance. What to watch: pilot projects that validate recovery gains under real mining conditions, and early case studies of environmental benefit. If successful, this approach could reshape how the mining sector meets demand for critical minerals without escalating environmental damage.
